RAPHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Raphael Pharmaceutical Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.51+0.11 (+7.86%)

Close on Oct 16, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Raphael Pharmaceutical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements Raphael Pharmaceutical filed with the SEC

Sep 1, 2026
CURRENT REPORT
Event dated Jul 30, 2026, from SEC EDGAR
Jul 17, 2026
CURRENT REPORT
Event dated Jul 16, 2026, from SEC EDGAR
Mar 24, 2026
CURRENT REPORT
Event dated Dec 31, 2025, from SEC EDGAR
Aug 11, 2025
CURRENT REPORT
Event dated Jul 31, 2025, from SEC EDGAR
Aug 11, 2025
CURRENT REPORT
Event dated Aug 7, 2025, from SEC EDGAR
Jan 14, 2025
CURRENT REPORT
Event dated Jan 8, 2025, from SEC EDGAR
Dec 30, 2024
CURRENT REPORT
Event dated Dec 23, 2024, from SEC EDGAR
Sep 11, 2024
CURRENT REPORT
Event dated Sep 5, 2024, from SEC EDGAR
Jun 26, 2024
CURRENT REPORT
Event dated Jun 26, 2024, from SEC EDGAR
May 2, 2024
Current report on Form 8-K
Event dated Apr 30, 2024, from SEC EDGAR
Mar 28, 2023
CURRENT REPORT
Event dated Mar 27, 2023, from SEC EDGAR
Oct 24, 2022
CURRENT REPORT
Event dated Oct 7, 2022, from SEC EDGAR
Jul 7, 2022
CURRENT REPORT
Event dated Jun 30, 2022, from SEC EDGAR
May 29, 2013
EASY ENERGY 8K
Event dated May 29, 2013, from SEC EDGAR
Oct 5, 2010
CURRENT REPORT DATED 10-5-10
Event dated Oct 5, 2010, from SEC EDGAR